- Chief Medical Officer
Dr. Kenneth (Ken) Somberg is the Chief Medical Officer of Covance. He has served in this capacity since joining Covance in 2009. In the role of Chief Medical Officer, Dr. Somberg oversees the physicians from phases I through IV, as well as Global Regulatory Affairs which includes regulatory strategy, regulatory submissions, and medical writing. As a member of the Executive Leadership Team for the Clinical Development and Commercialization Business, he contributes to business unit and corporate strategy and senior client relationships. Since 2012 he has chaired the company-wide Covance Scientific Council and in 2015 joined the Covance Executive Committee.
Dr. Somberg joined Covance after nearly 12 years at Novartis, where he progressed through numerous roles of increasing responsibility. Prior to joining Covance, he was Vice President and Global Franchise Head, drug regulatory affairs for Immunology and Infectious Diseases. He previously served as global head of clinical development for Transplantation and Infectious Diseases at Novartis.
Dr. Somberg received his medical degree from Baylor College of Medicine, completed his residency in internal medicine at Harbor-UCLA Medical Center, and his fellowship in gastroenterology at the University of California, San Francisco (UCSF). He served as Assistant Professor and Associate Medical Director of the Liver Transplantation Program at UCSF for five years prior to joining Novartis. Dr. Somberg also holds a master of business administration degree from Duke University and a Bachelor of Arts degree in human biology from Stanford University. He lives in Florham Park, New Jersey, with his wife and has two grown sons.